EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
AnaptysBio, Inc. (ANAB) had EBIT Margin of -117.55% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$22.26M |
|
$-38.63M |
|
-- |
|
$22.26M |
|
$48.43M |
|
$-26.17M |
|
$-12.42M |
|
$-38.59M |
|
$-38.59M |
|
$-38.63M |
|
$-38.63M |
|
$-38.63M |
|
$-38.63M |
|
$-26.17M |
|
$-27.17M |
|
28.81M |
|
28.81M |
|
$-1.34 |
|
$-1.34 |
|
| Balance Sheet Financials | |
$291.91M |
|
$1.63M |
|
$43.34M |
|
$335.25M |
|
$35.53M |
|
-- |
|
$344.46M |
|
$379.98M |
|
$-44.73M |
|
$-44.73M |
|
$-44.73M |
|
27.97M |
|
| Cash Flow Statement Financials | |
$-50.94M |
|
$51.25M |
|
$-79.09M |
|
$123.08M |
|
$44.30M |
|
$-78.78M |
|
$18.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-117.55% |
|
|
EBIT Margin |
-117.55% |
-- |
|
-173.34% |
|
-173.52% |
|
$-51.02M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.04 |
|
86.58 |
|
86.36% |
|
86.36% |
|
-11.52% |
|
86.36% |
|
$-1.60 |
|
$-1.77 |
|
$-1.77 |
|